3/21/2024 | 30069300 | VAY736, placebo vial BATCH 2037509 / PCN 2301193 (FOC) (TL/CT/23/000060 DATE 05/04/2023) | XXXXXXXXXX | 4 | PCS | 123.16 | SWITZERLAND | SAHAR AIR |
3/21/2024 | 30069300 | VAY736, placebo vial BATCH 2037509 / PCN 2301288 (FOC) (TL/CT/23/000060 DATE 05/04/2023) | XXXXXXXXXX | 46 | PCS | 1416.36 | SWITZERLAND | SAHAR AIR |
3/15/2024 | 30069300 | (NCV) (IMPORT FOR CLINICAL TRIAL USE) SAR443122-100MG OR PLACEBO | XXXXXXXXXX | 124 | SET | 28061.42 | UNITED KINGDOM | SAHAR AIR |
3/12/2024 | 30069300 | (NCV) (IMPORT FOR CLINICAL TRIAL USE) SAR441566 DRI17821 DOUBLE BLIND KIT 100 MG OR 50 MG OR PLACEBO TABLETS | XXXXXXXXXX | 56 | SET | 10654.93 | ITALY | SAHAR AIR |
3/12/2024 | 30069300 | (NCV) (IMPORT FOR CLINICAL TRIAL USE) SAR441566 DRI17821 DOUBLE BLIND KIT 100 MG OR 50 MG OR PLACEBO TABLETS | XXXXXXXXXX | 91 | SET | 17314.26 | ITALY | SAHAR AIR |
3/12/2024 | 30069300 | (NCV) (IMPORT FOR CLINICAL TRIAL USE) SAR441566 DRI17821 DOUBLE BLIND KIT 100 MG OR 50 MG OR PLACEBO TABLETS | XXXXXXXXXX | 103 | SET | 19597.46 | ITALY | SAHAR AIR |
3/12/2024 | 30069300 | IGE025 PLACEBO SYRINGE 150 milligram(mg) BATCH VVUA02101 (FOC) (TL/CT/24/000001 DATE 08/01/2024) | XXXXXXXXXX | 50 | PCS | 1476.09 | GERMANY | SAHAR AIR |
3/11/2024 | 30069300 | (FOC ITEMS) PLACEBO FOR OTT166 SOLUTION | XXXXXXXXXX | 3 | UNT | 166.02 | FINLAND | BANGALORE AIR |
3/11/2024 | 30069300 | PLACEBO TABLETS SAMPLES (NO COMMERCIAL VALUE FOR MACHINE TRIAL PURPOSE ONLY) | XXXXXXXXXX | 150000 | PCS | 781.89 | RUSSIA | SAHAR AIR |
3/11/2024 | 30069300 | APIKSABAN 5 MG PROCESSED PLACEBO (CORE TABLET)(FOC) | XXXXXXXXXX | 1 | NOS | 1.34 | TURKEY | SAHAR AIR |